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ABSTRACT
Objective: The present study is aimed to investigate the promising action of Dunaliella salina extract as a natural protector against Alzheimer’s 
disease (AD) and reported to possess a variety of activities, including antioxidant effects due to its ability to create large amount of carotenoids.
Methods: D. salina is a type of halophile green microalgae was used in the present study. 50 male rats were used in this study, where aluminum 
chloride was orally administered to induce AD in a dose of 100 mg/kg, daily for 6 weeks. Al-intoxicated rats treated orally daily with D. salina 
ethanolic extract for 6 weeks in a dose of 150 mg/kg b.wt., whereas standard anti-Alzheimer drug donepezil tartrate was administered at the dose 
of 10 mg/kg b.wt./day for 6 consecutive weeks. The anti-Alzheimer properties of D. salina extract were achieved through measuring the calmodulin 
(CaM) level, paraoxonase 1 (PON1) activity, the antiapoptotic marker (Bcl2), brain-derived neurotrophic factor (BDNF), the generation of the DNA 
adducts (8-hydroxy-2-deoxyguanosine [8-OHdG]/2-deoxy guanosine [2-dG]), and alteration in the expression of amyloid precursor protein, β-site 
APP-cleaving enzyme 1 (BACE1), and β-site APP-cleaving enzyme 2 (BACE2) in AD rats.
Results: The current results demonstrated that supplementation of AD rats with D. salina extract-enhanced CaM level, and increased PON1 activity, 
upregulated Bcl2 and BDNF, decreased the levels of DNA adducts (8-OHdG/2-dG), and suppressed the alterations of the expression levels of APP, 
BACE1, and BACE2-m RNAs as compared with those in AD rats.
Conclusion: It could be concluded that the biological activity of D. salina extract might be regulated by 9-cis b-carotene protecting the brain cells from 
the oxidative stress in AD rats.
Keywords: Dunaliella salina, Calmodulin, Paraoxonase 1, Bcl2, Brain-derived neurotrophic factor, Alzheimer’s disease, DNA adduct, Amyloid precursor 
protein.
INTRODUCTION
Alzheimer’s disease (AD) is characterized by extracellular deposition 
of β-amyloid plaques, neurofibrillary tangles, loss of synapses, neurons, 
and vacuolar degeneration. AD, the fourth leading cause of death in the 
USA, also characterized by neuropsychiatric symptoms including apathy, 
depression, aggression, agitation, sleep disruption, and psychosis [1]. 
The amyloid precursor protein and the microtubule-associated protein, 
tau, are two major proteins involved in AD pathology. The β-amyloid 
protein is produced from the amyloid β-protein precursor (APP) by 
two sequential proteolytic cleavages enzymes called secretases [2]. 
Studies also showed that the products of oxidative stress were found 
in neurofibrillary tangles and senile plaques in AD [3,4]. Therefore, 
special interest has been focused in establishing the therapeutic role 
of antioxidants in neurodegenerative disease such as AD. The natural 
antioxidants vitamin E, C, and β-carotene considerably decreased the 
symptoms associated with AD [5].
Among all natural sources studied to date, Dunaliella possesses the 
highest content of 9-cis β-carotene reaching levels up to 100 g/kg b.wt. 
β-carotene-rich Dunaliella powder has been commercially exploited 
in many countries since the 1980s [6-10]. Dunaliella salina is a type 
of halophile green microalgae especially contains potential bioactive 
compounds for recent biomedical and pharmaceutical values [11]. It 
has been reported that due to the abundance of β-carotene, which is 
an antioxidant as well as a vitamin A precursor, D. salina is a popular 
pro-vitamin A food supplement and cosmetic additive [12]. It was 
demonstrated that D. salina exhibits strong protective effects on 
ultraviolet B radiation-induced corneal oxidative damage in mice, which 
seems to be caused by the increase of antioxidant enzyme activity and 
the inhibition of lipid peroxidation. Research performed at the Cancer 
Research Centre of Hawaii showed that D. salina contains a certain 
type of β-carotene called 9-cis β-carotene, which is up to ten times 
stronger at preventing cancer than ordinary β-carotene [13]. Clinical 
studies showed that whole dried D. salina cells are an effective source of 
bioavailable carotenoids and 14 weeks of supplementation with D. salina 
can produce favorable shifts oxidative mutagens in humans [14].
Although several works have been focused on the AD therapy, D. salina 
alga has been not investigated yet. Therefore, the present study aimed to 




Donepezil and all chemicals were purchased from Sigma Co. (USA) 
and aluminum chloride from BDH Laboratory Supplies, Poole (UK). 
TRIzol reagent was bought from Invitrogen (Germany). The reverse 
transcription (RT) and polymerase chain reaction (PCR) kits were 
obtained from Fermentas (USA). SYBR Green Mix was purchased from 
Stratagene (USA).
Collection of D. salina and ethanolic extract preparation
D. salina (Strain No. NIES-2257) was isolated by spreading 0.1 ml 
of water samples collected from the Egyptian Company for Salts 
and Mineral (EMISAL) effluent ponds using BG11 media [15] for 
algal isolation with addition of NaCl (100 g/l) into Petri dishes 
containing 1.5% agar for solidification. Single colonies of algae 
were then recultivated in the specified liquid media as nonaxenic 
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batch cultures (50 ml) at 25±2°C and 24 hr with continuous white 
fluorescent lamp intensity ≈2500 Lux. Cultivation was carried out 
on an open pond with a capacity of 70 L containing 55 L of growth 
media. After cultivation, D. salina biomass was harvested using 
electro flocculation method.
About 100 g of D. salina powder were soaked in ethanol (80%) and 
shacked on shaker (Heidolph UNIMAX 2010) for 48 hr at 150 rpm. 
The extract was filtered using a Buchner funnel and Whatman No. 4 
filter paper and the algal residue was reextracted with the addition of 
fresh ethanol (80%) for another two times. Combined filtrates were 
concentrated using Rotary evaporator (Heidolph-Germany) at 40°C 
under vacuum. The resulting dry extract was evaporated on a rotary 
vacuum evaporator to dryness [16]. The dry extract was stored at −20°C 
in freeze and kept for further analysis.
Experimental animals
Animals
Male Wistar rats (180-200 g) procured from Central Animal House, 
National Research Centre (NRC), were used. Animals were acclimatized 
to the laboratory conditions at room temperature before the 
experimentation. Animals were kept under standard conditions of a 
12 hr light/dark cycle with food and water ad-libitum in plastic cages 
with soft bedding. All the experiments were carried out between 9.00 
and 15.00 hr. The protocol was approved by the NRC Ethics Committee 
Guidelines for the use and care of animals.
Drugs and treatment schedule
Aluminum chloride (AlCl3) (CDH, India) solutions were made freshly 
at the beginning of each experiment. For oral administration, AlCl3 
was dissolved in drinking water and administered in a dose of 
100 mg/kg, p.o. was administered to rats daily for 6 weeks 0.5 ml/100 g 
body weight [17]. Donepezil tartrate (10 mg/kg b.wt./day) diluted in 
ultrapure water daily for 6 weeks [18]. Animals were randomized into 
five groups (50 adult male Sprague–Dawley rats) based on their body 
weight. Each group had 10 numbers of animals. The groups were as 
follows:
Group 1: Normal control rats.
Group 2: Normal control rats treated with D. salina.
Group 3:  Serving as Al-intoxicated rats were orally administered with 
AlCl3.
Group 4:  Al-intoxicated rats treated orally daily with D. salina ethanolic 
extract for 6 weeks in a dose of 150 mg/kg b.wt. [19].
Group 5: Al-intoxicated rats orally administered daily with standard drug.
Brain tissue sampling and preparation
At the end of the experiment, the rats were fasted overnight, subjected 
to anesthesia with diethyl ether and sacrificed. The whole brain of 
each rat was rapidly dissected, washed with isotonic saline, and dried 
on filter paper. Each brain was divided sagittally into two portions. 
The first portion was weighed and homogenized in ice-cold medium 
containing 50 mMTris/HCl and 300 mM sucrose at pH 7.4 to give a 10% 
(w/v) homogenate [20]. This homogenate was centrifuged at 1400 ×g 
for 10 minutes at 4°C. The supernatant was stored at −80°C and used 
for biochemical analyses that included antioxidant enzyme CaM and 
PON1 level. The ethical conditions were applied such that the animals 
suffered no pain at any stage of the experiment, and the study was 
approved by the Ethics Committee of the NRC. Animals were disposed 
of in bags provided by the Committee of Safety and Environmental 
Health, NRC.
Biochemical analyses
The activity of CaM as an activator of cAMP phosphodiesterase was 
assayed in brain tissue homogenate by the spectrophotometric 
method according to Garg et al. [21] while, PON1 was determined in 
brain tissue by ELIZA technique method. Brain Bcl2 was determined 
by ELISA technique according to the method of Barbareschi et al. [22]. 
Brain-derived neurotrophic factor (BDNF) was determined by ELISA 
technique according to the method of Barakat-Walter [23].
Determination of 8-hydroxy-2-deoxyguanosine (8-OHdG)/2-deoxy 
guanosine (2-dG) in brain tissues by high-performance liquid 
chromatography (HPLC)
DNA was extracted from rat brain by homogenization in buffer 
containing 1% sodium dodecyl sulfate, 10 mM Tris, 1 mM EDTA 
(pH 7.4), and an overnight incubation in 0.5 mg/ml proteinase K at 
55°C. Homogenates were incubated with RNase (0.1 mg/ml) at 50°C 
for 10 minutes and extracted with chloroform/isoamyl alcohol. The 
extracts were mixed with 3M sodium acetate and two volumes of 100% 
ethanol to precipitate DNA at −20°C. The samples were washed twice 
with 70% ethanol, air-dried for 15 minutes, and dissolved in 100 μl of 
10 mM Tris/1 mM EDTA (pH 7.4) [24]. DNA was then digested and the 
adduct 8-OHdG was measured with HPLC equipped with a Coul Array 
system (Model 5600). Analytes were detected on two coulometric array 
modules, each containing four electrochemical sensors attached in 
series, which allows identification targets based on reduction potential. 
The UV detection was set to 260 nm. The HPLC was controlled and 
the data acquired and analyzed using Coul Array software. The 
mobile phase was composed of 50 mM sodium acetate 5% methanol 
at pH 5.2. Electrochemical detector potentials for 8- OHdG and 2-dG 
were 120/230/280/420/600/750/840/900 mV, and the flow rate was 
1 ml/minute.
Gene expression analysis
Extraction of total RNA and complementary DNA (cDNA) synthesis
Liver tissues of male rats were used to extract the total RNA using 
TRIzol® Reagent (Invitrogen, Germany) Kit. The isolation method was 
carried out according to the manufacturer’s instructions of the above 
kit. Approximately, 50 mg of the liver tissues were mixed with some 
drops of liquid nitrogen and homogenized in 1 ml of TRIzol® Reagent in 
autoclaved mortar. Afterward, total RNA was dissolved and preserved 
in diethylpyrocarbonate-treated water up to use.
To assess the RNA yield and purity of the total RNA, RNAse-free DNAse 
I (Invitrogen, Germany) was used to digest DNA contamination. A small 
drop of isolated RNA was examined photospectrometrically at 260 nm. 
The purity of total RNA was determined between 1.8 and 2.1 to be good 
purified when it examined by photospectrometer at the 260/280 nm 
ratio. To avoid RNA damaging, aliquots of RNA were prepared after 
isolation for either RT reaction or otherwise for storing at −80°C up to 
use.
To synthesize the cDNA isolated RNA from liver tissues was reverse 
transcribed into cDNA. The reaction volume was carried out in 20 µl. 
The reaction volume was prepared according to the instructions of 
the RevertAid TM First Strand cDNA Synthesis Kit (MBI Fermentas, 
Germany). The RT reaction was performed for 10 minutes at 25°C. 
Afterward, the tubes of the reaction were put in thermocycler machine 
for 60 minutes at 42°C, and then, the reaction was terminated for 
5 minutes at 99°C. The PCR products containing the cDNA were kept at 
−20°C up to use for DNA amplification [25,26].
Quantitative real-time PCR (qRT-PCR)
A step one real-time PCR system (Applied Biosystem, USA) was used 
to assess the copy of the cDNA of male rats to detect the expression 
values of the tested genes. To perform the PCR reaction, a volume of 
25 ml of reaction mixtures was prepared containing 12.5 ml of SYBR® 
green (TaKaRa, Biotech. Co. Ltd.), 0.5 ml of 0.2 mM forward and reverse 
primers, 6.5 ml DNA-RNA free water, and 2.5 ml of the synthesized cDNA. 
The cDNA was propagated using reaction program consisted of 3 steps. 
In the first step, the PCR tubes were incubated at 95°C for 3 minutes. 
In the second step, the reaction program consisted of 50 cycles. Each 
cycle of them consisted of 3 substeps: (a) 15 seconds at 95°C; (b) 
30 seconds at 60°C; and (c) 30 seconds at 72°C in the third step; the 
reaction program consisted of 71 cycles. The first cycle of them started 
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at 60°C for 10 seconds, and then, the followed cycles increased about 
0.5°C every 10 seconds up to 95°C. A melting curve of the reaction was 
performed for each qRT-PCR termination at 95°C to assess the quality 
of the primers. To verify that the reaction of the qRT-PCR does not 
have any contamination PCR tubes containing nontemplate control 
were used. The sequences of the specific primer of the genes used are 
listed in Table 1. The relative quantification of the target genes to the 
reference (β-actin) was determined using the 2−ΔΔCT method.
Statistical analyses
Data were analyzed by one-way analysis of variance using the Statistical 
Package for the Social Sciences program, version 11 followed by least 
significant difference to compare significance between groups. The 
difference was considered significant when p≤0.05.
RESULTS AND DISCUSSION
Effect of D. salina extract on CaM level and PON1 activity
Table 2 showed the effect of D. salina extract on AD-induced rats, through 
measuring CaM and PON1 levels in rats’ brain tissue. The results showed 
an insignificant change in CaM level in normal rats treated with D. salina 
extract comparing with normal control rats. While a significant increase 
in PON1 activity as compared to normal untreated one was observed 
with percentage 15.32%. AD-induced rats showed a significant decrease 
in CaM level (62.41%), and PON1 activity (27.36%) comparing with 
normal control. Treatment of intoxicated rats with D. salina extract 
demonstrated a significant increase in CaM with improvement 
percentage 32.62%, whereas an insignificant change in PON1 activity 
(34.47%) as compared to normal control rats was detected. Standard 
drug recorded a significant decrease in CaM level with amelioration 
percentage 25.53%, whereas insignificant change in PON1 activity 
(17.73%) comparing with normal control rats was recorded.
The present results demonstrated a significant reduction in both 
CaM and PON1 activity in AD rats. In accordance with the present 
result McLachlan et al. [30] declared, the calcium binding proteins in 
the Alzheimer-induced rats, frontal, temporal, parietal cortex, and 
subjacent white matter CaM content was significantly reduced (66%). 
The author added that CaM extracted from temporal cortex also 
demonstrated reduced efficacy as an activator of 3’,5’ cyclic nucleotide 
phosphodiesterase. Reduced concentrations of these important proteins 
may affect calcium homeostasis and the regulation of a large number of 
calcium-mediated brain functions. It was suggested that an imbalance of 
calcium levels in cells precedes the signaling pathway malfunctions and 
neuronal deterioration observed in neurodegenerative diseases [31].
Calmodulin binding proteins linked to the formation of amyloid plaques. 
The “amyloid hypothesis” is arguably the predominant hypothesis for 
the symptoms and progression of AD. CaM is significantly decreased in 
the brains of AD individuals [30]. In spite of this, the existing CaM can 
interact with several proteins in the amyloid pathway. It is based on the 
aggregation of Aβ peptides plus a multitude of other components to 
form extracellular amyloid plaques in the brains of AD sufferers [31].
Regarding PON1, it exerts a potent protective role in vivo against 
oxidative (OxS)-induced damage [32,33]. Only relatively few studies 
have examined the relationship between biochemical determinants of 
this HDL-associated protein and dementia, the decrease in antioxidant 
protection by PON-1 might be one of the reasons for the exacerbation 
of OxS observed in dementia patients [34-37]. In addition, PON1 is 
an enzyme with multiple physiological functions and roles. Relevant 
to this notion, studies conducted in knockout mice have shown 
that PON-1 may serve as a key determinant in the detoxification of 
organophosphate pesticides that, in turn, are regarded as strong risk 
factors for neurological diseases, such as ate onset Alzheimer’s disease 
(LOAD) and Parkinson’s disease [38].
Effect of D. salina extract treatment on brain antiapoptotic marker 
(Bcl2) and BDNF in Al-intoxicated rats
Table 3 declared in a significant change in the antiapoptotic marker 
(Bcl-2) and BDNF in normal rats treated with D. salina as compared to 
normal untreated rats. AD rats demonstrated a significant decrease in 
Bcl-2 and BDNF with percentages of 57.46 and 43.11%, respectively. 
Treatment of AD-induced rats with D. salina extract recorded significant 
reduction in both Bcl2 and BDNF levels with amelioration 33.65% and 
30.26%, respectively, compared with 27.20% and 24.70%, respectively, 
for standard drug.
Respecting to the Bcl2 and BDNF levels, the present data showed a 
significant decrease in brain levels of Bcl2 and BDNF in Al-intoxicated 
rats. AlCl3 decreased Bcl2 expression and increased proapoptotic 
marker (Bax) expression in the rat hippocampus. Altered Bax/Bcl2 ratio 
Table 1: Primer sequences used for qPCR
Gene Primer sequence (5′-3′) References
APP F: ACT GGC TGA AGA AAG TGA CAA T Stein and 
Johnson [27]R: AGA GGT GGT TCG AGT TCC TAC A
BACE1 F: GCG CTT GCC ATG TGC AC Luo et al. [28]
R: TGC CGT AAC AAA CGG ACC TT
BACE2 F: AAA TTT CTG GGC CCT TTT CC Luo et al. [28]
R: GGG CTC ATT CAG AGC CTG TG
β-actin F: GGAGATTACTGCCCTGGCTCCTA Deng et al. [29]
R: GACTCATCGTACTCCTGCTGCTG
F: Forward primer, R: Reverse primer, APP: Amyloid β-protein precursor, 
BACE1: β-site APP-cleaving enzyme 1, BACE2: β-site APP-cleaving enzyme 2, 
qPCR: Quantitative polymerase chain reaction
Table 2: Effect of D. salina extract on CaM level and PON1 activity
Groups Parameters
CaM (ng/ml) PON1 (U/L)
Normal control 2.80±0.13a 210.90±10.20a
D. salina treated normal control 2.76±0.10a 243.20±10.50c
% change 3.16 15.32
AD 1.06±0.95b 153.20±12.13d
% change 62.41 27.36
D. salina treated AD rats 1.98±0.52c 225.90±14.20a
% change 29.78 7.11
% of improvement 32.62 34.47
Standard drug treated AD rats 1.78±0.42d 190.59±11.50a
% change 36.87 9.63
% of improvement 25.53 17.73
Data are means±SD of 10 rats in each group. Unshared letters between groups 
are the significance value at P≤0.05. SD: Standard deviation, D. salina: Dunaliella 
salina, AD: Alzheimer’s disease, PON1: Paraoxonase 1, CaM: Calmodulin
Table 3: Effect of D. salina extract treatment on brain 








Normal control 118.00±6.94a 90.00±4.00a
D. salina treated normal control 119.00±7.96a 89.23±3.22a
% change 0.85 0.86
AD 50.20±4.10b 51.20±5.20b
% change 57.46 43.11
D. salina treated AD rats 89.90±3.17c 78.43±2.11c
% change 23.81 12.86
% of improvement 33.65 30.26
Standard drug treated AD rats 82.30±3.17c 73.43±2.11c
% change 30.25 18.41
% of improvement 27.20 24.70
Data are means±SD of 10 rats in each group. Unshared letters between groups 
are the significance value at p≤0.05. SD: Standard deviation, D. salina: Dunaliella 
salina, AD: Alzheimer’s disease, BDNF: Brain-derived neurotrophic factor
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is critical to Al-induced apoptosis leading to activation of caspase-3 
and release of cytochromec [39,40]. Kumar et al. [17] reported that Al 
increases p53 protein expression by activating p38 MAPK to initiate 
apoptosis and this is accompanied by a marked inhibition of Bcl-2 and 
increased Bax expression. Takuma et al. [41] showed marked decrease 
in the BDNF mRNA level in the hippocampus due to ovariectomy in mice. 
Disruption of the pro-inflammatory cytokine/neurotrophin balance by 
Al plays an important role in the neurodegenerative disease [42].
Effect of D. salina extract on the DNA adducts
Determination of the 8-OHdG generation in brain tissues of AD-induced 
rats’ genome following D. salina extract treatment is summarized in 
Fig. 1. Fig. 1 showed that AD-induced rats revealed a significant increase 
in the 8-OHdG/2-dG ratio compared with those in control rats. However, 
the results showed that 8-OHdG/2-dG ratio following treatment of 
AD-induced rats with D. salina extract decreased significantly compared 
with those in AD-induced rats and reached relatively similar to that of 
the control group. Moreover, the ratio of 8-OHdG/2-dG generation in 
AD rats treated with donepezil (10 mg/kg), as reference drug for AD 
treatment, was decreased significantly compared with those in AD rats 
(Fig. 1).
The results of the present study revealed that AD rats exhibited 
significantly high levels of DNA adducts in the form of the ratio 
of 8-OHdG/2-dG and high expression levels of AD-related genes 
(APP, BACE1, and BACE2). These results are in the same line of Guix 
et al. [43], who reported that levels of brain nitric oxide (BNO) which is 
responsible for increase the oxidation and DNA damage are increasing 
in neurodegenerative diseases such as AD, stroke, and Parkinson’s 
diseases due to the formation of highly reactive peroxynitrite. Moreover, 
Dorheim et al. [44]reported that the increase in the levels of BNO in AD 
patients may result from the activation of NO synthesis, in which it is 
also increasing in the brain tissue of AD patients, suggesting that BNO 
may play a role in neuronal cell degeneration in the AD disease.
Effect of the D. salina extract on the expression of AD genes
The expression levels of the genes encoding AD enzymes including APP 
and β-site APP-cleaving enzyme 1 and 2 (BACE1 and BACE2) in brain 
tissues of AD rats were quantified by real-time RT-PCR (Figs. 2-4). The 
results revealed that AD-induced rats revealed a significant increase 
in the expression of APP, BACE1, and BACE2 genes compared with 
those in control rats. The percentages of the mRNA expression of APP, 
BACE1, and BACE2 genes in AD rats were 513.5%, 602.8%, and 332.5%, 
respectively, compared with those in control rats (Figs. 2-4). In contrary, 
the expression levels of APP, BACE1, and BACE2 genes decreased 
significantly in AD rats treated with D. salina extract compared with 
those in AD rats. The percentage of the mRNA expression of APP, BACE1, 
and BACE2 genes in AD rats treated with D. salina extract decreased 
to 234.5%, 311.1%, and 183.1%, respectively, compared with those in 
AD rats (Figs. 2-4). Moreover, the percentage of the mRNA expression 
of APP, BACE1, and BACE2 genes decreased to 226.9%, 255.6%, and 
166.2%, respectively, in AD rats treated with donepezil compared with 
those in AD rats.
Some reports suggested that oxidative stress and DNA damage are 
associated with signal transduction pathways of N-methyl-D-aspartate 
receptors (NMDA), in which they are glutamate receptors and ion 
channel protein found in nerve cells receptors. In this pathway, the 
activation of NMDA receptors leads to increased intracellular calcium 
in the postsynaptic neuron, which, in turn, binds to CaM and triggers 
the activation of the NOS enzyme opening a gate for the electron 
flux into the active center of the NOS in brain tissue [45,46]. Thus, it 
gives rise to the elevated levels of BNO that are apparently involved in 
neurodegeneration by different mechanisms, including oxidative stress 
and activation of intracellular signaling mechanisms [47].
The present study exhibited that treatment of AD rats with D. salina 
extract decreased significantly the levels of DNA adducts and the 
expression levels APP, BACE1, and BACE2 genes. The formation of 
Fig. 1: Generation of 8-hydroxy-2-deoxyguanosine (8-OHdG) in 
the brain tissues of Alzheimer’s disease-induced rats treated with 
Dunaliella salina extract. DNA damage was expressed as the ratio 
of oxidized DNA base (8-OHdG) to nonoxidized base (2-deoxy 
guanosine) in brain DNA. Data are presented as mean±standard 
error of mean, a,b,cfollowed by different superscripts are 
significantly different (p≤0.05)
Fig. 2: Expression levels of amyloid β-protein precursor gene in 
brain tissues of Alzheimer’s disease-induced rats treated with 
Dunaliella salina extract. Data are presented as mean±standard 
error of mean, a,b,cfollowed by different superscripts are 
significantly different (p≤0.05)
Fig. 3: Expression levels of BACE1 gene in brain tissues of 
Alzheimer’s disease-induced rats treated with Dunaliella 
salina extract. Data are presented as mean±standard error of 
mean, a,b,cfollowed by different superscripts are significantly 
different (p≤0.05)
Fig. 4: Expression levels of BACE2 gene in brain tissues of 
Alzheimer’s disease-induced rats treated with Dunaliella 
salina extract. Data are presented as mean±standard error of 
mean, a,b,cfollowed by different superscripts are significantly 
different (p≤0.05)
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Alzheimer’s Aβ peptide is initiated when APP is cleaved by the BACE1 
and BACE2 enzymes [48]. It has been reported that D. salina is known 
to have high carotenoid content [19]. Moreover, D. salina extracts 
are shown to contain high levels of antioxidant activity in the both 
in vitro and in vivo studies [49]. These studies demonstrated that the 
ameliorative effect of D. salina is attributed to the 9-cis b-carotene 
content [49].
Several studies revealed that 9-cis b-carotene inhibited the chromosomal 
breaks (micronucleus formation) in the lymphocytes of human 
in vitro [49]. Moreover, other reports indicating that the therapeutic 
role of 9-cis b-carotene is attributed to its antioxidant properties and 
inhibition of the metabolic pathway of the most pro-mutagens [50,51]. 
Thus, the results of the current work could be suggested that D. salina 
extract is able to DAN adducts and alterations of AD-related genes 
through the protective pathway of 9-cis b-carotene which protect the 
cells from the oxidative stress occurred in the degenerative cells of AD 
rats.
Moreover, several reports revealed that β-carotene extracted from 
Dunaliella sp., which contain high levels of bioavailable 9-cis, have in 
fact provided verification of a lower incidence of several kinds of cancer 
and degenerative disorders [50].
CONCLUSION
D. salina extract is capable to suppress the DNA adducts and decrease 
the alterations in the AD-related genes in DA rats. The biological activity 
of D. salina extract is might be regulated by 9-cis b-carotene which it is 
coinciding with degenerative protection in the oxidative stressed cells 
in AD patients.
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